| Filed On | Filing |
|---|---|
| 15 Nov 2024 |
Form 4: snyderman nancy lynn Md, Director
Returned 14,944 shares to the issuer ($1.06M) · Disposed of 14,167 Stock Option (Right to Buy) (Disposition to Issuer) ($653K) |
| 15 Nov 2024 |
Form 4: Lopez Esteban, Director
Returned 6,600 shares to the issuer ($469K) · Disposed of 10,000 Stock Options (Right to buy) (Disposition to Issuer) ($113K) |
| 15 Nov 2024 |
Form 4: Kiernan Jane E, Director
Returned 19,861 shares to the issuer ($1.41M) |
| 15 Nov 2024 |
Form 4: Woock John, EVP, Chief Mktg/Strtgy Officer
Returned 77,403 shares to the issuer ($5.5M) · Disposed of 13,125 Performance-Based Restricted Stock Units (Disposition to Issuer) · Disposed of 19,136 Stock Options (Right to buy) (Disposition to Issuer) ($1.05M) |
| 15 Nov 2024 |
Form 4: Sama Rinda, Chief Operating Officer
Returned 84,462 shares to the issuer ($6M) · Disposed of 13,125 Performance-Based Restricted Stock Units (Disposition to Issuer) · Disposed of 20,981 Stock Options (Right to buy) (Disposition to Issuer) ($1.08M) · 1 more |
| 15 Nov 2024 |
Form 4: Noblett Karen, Chief Medical Officer
Returned 34,428 shares to the issuer ($2.44M) · Disposed of 7,500 Performance-Based Restricted Stock Units (Disposition to Issuer) · Disposed of 14,961 Stock Option (Right to Buy) (Disposition to Issuer) ($1M) · 1 more |
| 15 Nov 2024 |
Form 4: McNamara Robert, Director
Returned 14,861 shares to the issuer ($1.06M) · Disposed of 18,333 Stock Option (Right to Buy) (Disposition to Issuer) ($763K) |
| 15 Nov 2024 |
Form 4: Keese Kari Leigh, Chief Financial Officer
Returned 40,362 shares to the issuer ($2.87M) · Disposed of 3,125 Performance-Based Restricted Stock Units (Disposition to Issuer) |
| 15 Nov 2024 |
Form 4: Ford Alfred J Jr, Chief Commercial Officer
Returned 43,450 shares to the issuer ($3.08M) · Disposed of 11,250 Performance-Based Restricted Stock Units (Disposition to Issuer) · Disposed of 4,655 Stock Option (Right to Buy) (Disposition to Issuer) ($210K) |
| 15 Nov 2024 |
Form 4: Demski David M, Director
Returned 9,542 shares to the issuer ($677K) · Disposed of 10,000 Stock Options (Right to buy) (Disposition to Issuer) ($193K) |
| 15 Nov 2024 |
Form 4: Cohen Raymond W, Director
Returned 292,731 shares to the issuer ($20.8M) · Disposed of 31,125 Performance-Based Restricted Stock Units (Disposition to Issuer) · Disposed of 303,227 Stock Option (Right to Buy) (Disposition to Issuer) ($18.6M) |
| 15 Nov 2024 |
Form 4: Carrel Michael H, Director
Returned 17,861 shares to the issuer ($1.27M) · Disposed of 15,000 Stock Option (Right to Buy) (Disposition to Issuer) ($686K) |
| 12 Nov 2024 |
Form 4: snyderman nancy lynn Md, Director
Gave 5,000 shares as a gift |
| 03 Oct 2024 |
Form 4: Keese Kari Leigh, Chief Financial Officer
Sold 2,961 shares ($206K) |
| 25 Jul 2024 |
Form 4: Cohen Raymond W, Director
Received 103,896 shares by exercise or conversion ($2.38M) |
| 02 Feb 2024 |
Form 4: Sama Rinda, Chief Operating Officer
Received 28,000 shares by exercise or conversion |
| 02 Feb 2024 |
Form 4: Noblett Karen, Chief Medical Officer
Received 27,500 shares by exercise or conversion · Sold 11,288 shares ($765K) |
| 02 Feb 2024 |
Form 4: Woock John, EVP, Chief Mktg/Strtgy Officer
Received 28,000 shares by exercise or conversion · Sold 15,899 shares ($1.08M) |
| 02 Feb 2024 |
Form 4: Ford Alfred J Jr, Chief Commercial Officer
Received 25,500 shares by exercise or conversion · Sold 16,615 shares ($1.13M) |
| 02 Feb 2024 |
Form 4: Keese Kari Leigh, Chief Financial Officer
Received 6,167 shares by exercise or conversion · Sold 3,489 shares ($236K) |
Loading...